Liora Neurotech exists to shift psychiatry toward a new paradigm of dynamic, metabolic precision medicine grounded in continuous physiological intelligence. This is to move beyond psychiatry’s static diagnostics, fixed therapeutics, and crisis-oriented clinical model.
We are beginning by enabling relapse predictions for individuals living with schizophrenia and bipolar disorder - to achieve our first goal of improving their autonomy and wellbeing. We seek to reduce acute relapse events which give rise to emergency-hospitalisation cycles for many. By breaking the cycle, we aim to reduce accruing injury to cognitive and physical function, trauma, and overall heightened future hospitalisation risk.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.liora.health
- Keywords
- Cicada Innovations.
Liora Neurotech Questions
Liora Neurotech's website is https://www.liora.health
Liora Neurotech's LinkedIn profile is https://www.linkedin.com/company/liora-neurotechnologies
Liora Neurotech has
1 employees.
View email and phone details for 1
employees at Liora Neurotech.
Liora Neurotech's industry is
Biotechnology Research
Liora Neurotech's top competitors are
Blackbird,
Next Chapter,
Sprout Materials,
Welv,
One Kidney,
Pickc,
Cicada Innovations,
Tap The Gap,
Oncorevive,
Algenie.
Liora Neurotech's categories are Biotechnology Research
Liora Neurotech's founding year is 2024
